From £6.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £6.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

FeverTree continues to focus on a certain type of consumer/user…and investor

By Chris Bailey | Tuesday 12 September 2023


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


I have some breaking news for you all. Back in May last year, I observed that “I continue to no longer recommend selling your FeverTree (FEVR) shares (although I still haven’t tried its products)”. This now needs to be updated, as the other week J Sainsbury (SBRY) had a FeverTree lemonade on offer and I did try the “clear, sparkling lemonade” product (although I failed to follow its suggestion to mix the “finest fruit cups” with vodkas or gin). Otherwise…how do I feel about the company’s first half results?

Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

Time left: 07:49:26